FTSE 100 to extend losses as Trump labels China 'currency manipulator'
The FTSE 100 has fallen around 5% since the start of the month
Sector
Health
1090 stories · page 54 of 55
Cellmid subsidiary Advangen International enters into agreement with K2B Co Ltd for distribution of évolis products
Avangen is engaged in the development and sale of clinically validated anti-ageing products for skin, hair and body.
newtec test odin
newtec testnewtec testnewtec testnewtec testnewtec testnewtec testnewtec test
Shares of Obalon Therapeutics plunge a day after stock surged 233% on upbeat product news
Obalon is launching a $3 million direct offering in a common move to take advantage of Wednesday's massive rally
Organovo tumbles after fiscal 4Q revenue miss, extended timeline for liver tissue program
CEO Taylor J Crouch says preclinical development of 3D-bioprinted tissues will extend into calendar 2020
Obalon Therapeutics rockets on clinical data showing its Obalon Balloon System works safely to treat obesity
The San Diego company says average weight loss for patients receiving three balloons and six months of therapy was nearly 22 pounds
Judges Scientific's focus is paying dividends
Judges Scientific PLC (LON:JDG) posted strong 2018 full year results with revenues at £77.9mln (9% up year-on-year, including 5.5% organic growth) and adjusted operating profit at £14.7mln (35% up year-on-year). Revenue growth was solid acr
Organovo expects FDA meeting in 2019 on 3D-bioprinted tissues for liver disease treatment
The biotech estimates that it has sufficient funds to meet operating and capital requirements through fiscal 2020
Senseonics rallies after FDA approval of use of implantable glucose monitor during MRI
All other continuous glucose monitors must be removed before an MRI scan, according to the company
TransEnterix's digital laparoscopy device gets green light from FDA
The company's Senhance Ultrasonic system is approved for use in the US for laparoscopic colorectal, gynecological and gallbladder removal surgery
PolarityTE prepares for launch of SkinTE in 2019; posts $1.1M in revenue in fiscal 4Q
PolarityTE focuses on developing a range of regenerative tissue products and SkinTE is its flagship product for skin repair and reconstruction
Puration shares pop after saying it's pouring more resources in cannabis beverage business
Company wants to take advantage of the move by major beverage players into the cannabis sector
TransEnterix shares pop after FDA clears robotic surgery instruments
The FDA’s clearance of the 3 millimeter diameter instruments will allow the company’s Senhance robotic surgery system to be used for microlaparoscopic surgeries
Judges Scientific PLC - 2018 Interim Results
Judges Scientific reported results for the first half of 2018. The period included a first-time contribution from Oxford Cryosystems, which was acquired in July 2017. Organic growth of order intake and sales was solid and well in line with
Organovo reports smaller loss and sharp fall in revenue
The net loss for the quarter was lower compared to last year but revenues slid
TransEnterix posts bigger 2Q loss although revenue tops expectation
Shares of TransEnterix tumbled following a bigger-than-expected earnings miss
CRISPR stocks in focus after research shows edited cells might cause cancer
CRISPR Therapeutics shares recovered after it said ‘the theoretical risks’ described in the papers didn’t apply to its ‘high-efficiency gene correction’ program
Shares of Organovo fall after it narrows fiscal 2018 guidance
The San Diego company, which develops 3D human tissue models, also missed fiscal 3Q revenue estimates
TransEnterix shares pop after FDA approves its robotic surgery system for more procedures
Company says FDA clearance doubles total addressable market in US to more than three million annual procedures
Obalon Therapeutics shares plunge after bigger-than-expected 1Q loss on sliding revenue
The San Diego medical device maker missed Wall Street earnings estimates after revenue declined